March 19, 2013
TB Alliance Licenses Late-stage TB Program to CSIR-OSDD
OSDD to assume development, commercialization for promising TB regimen March 17, 2013
UNITAID and TB Alliance Call For More Action Against Childhood Tuberculosis
In TB Fight, Children Must Be a Priority March 17, 2013
World TB Day 2013 Toolkit
Get Involved Now March 3, 2013
David Norton Appointed to TB Alliance’s Board of Directors
Former Johnson & Johnson Chairman of Pharmaceuticals brings global product development and commercialization expertise February 24, 2013
PSI CEO Karl Hofmann Elected President of TB Alliance’s Stakeholders Association, Joins Board of Directors
Global health expert and diplomat to lend skills, support to optimize new TB drug introductions February 24, 2013
Stakeholders Association Elects New Leadership
January 10, 2013
Improving the Therapeutic Potential of Pyrazinamide
US NIH AIDS Clinical Trials Group Grant Supports the Investigation of Methods to Overcome Drug-Resistance and Reduce Toxicity of TB Treatment January 6, 2013